throat
swab
sampl
studyrel
monitor
perform
follow
guidanc
manufactur
copan
diagnost
inc
murrieta
ca
usa
sampl
store
sent
batch
test
followup
finish
quantit
rtpcr
test
method
studi
valid
teddi
clinic
research
laboratori
wuhan
citi
china
shown
method
valid
includ
precis
accuraci
specif
sensit
follow
guidelin
cap
clsi
miqe
due
limit
number
type
sampl
nasopharyng
swab
sampl
previous
test
posit
use
commerci
vitro
diagnost
kit
use
valid
test
summari
result
follow
precis
valid
coeffici
variat
cv
valu
valid
sampl
less
met
valid
criteria
pass
inter
intra
batch
precis
valid
cv
valu
valid
sampl
less
bia
less
met
valid
criteria
pass
accuraci
verif
specif
defin
consist
test
result
theori
actual
test
result
use
known
clinic
sampl
valid
cv
valu
valid
sampl
less
test
result
consist
actual
test
result
sensit
valid
e
gene
rna
standard
provid
roch
diagnost
use
sensit
valid
test
lloq
lowest
limit
quantif
lod
limit
detect
determin
use
e
gene
rna
standard
lower
limit
quantifc
assay
copiesul
limit
detect
pcr
assay
copyul
kit
contain
specif
primer
probe
design
detect
three
gene
rna
depend
rna
polymeras
rdrp
n
gene
e
gene
egen
use
viru
screen
elimin
sarsrel
covc
rdrp
n
gene
use
confirm
infect
although
rdrp
gene
specif
select
e
gene
quantifi
viral
load
instead
rdrp
gene
amplif
effici
rdrp
gene
lower
e
gene
quantif
perform
use
egen
rna
standard
provid
roch
diagnost
shanghai
ltd
egen
assay
kit
detect
sar
well
batassoci
sarsrel
virus
sarbecoviru
cross
reactiv
found
common
human
respiratori
cov
hku
merscov
gene
sequenc
analysi
sinc
sampl
studi
patient
clinic
diagnos
pneumonia
wuhan
sar
cov
infect
detect
logic
use
e
gene
target
quantif
viral
load
sampl
detect
rdrp
n
gene
also
test
patient
first
visit
sampl
assay
control
includ
addit
eav
rna
extract
control
tib
germani
directli
sampl
control
monitor
entir
process
rna
extract
gene
detect
addit
neg
water
posit
control
differ
posit
pcr
plate
monitor
amplif
process
standard
laboratori
process
mitig
cross
contamin
viral
rna
extract
use
magna
pure
dna
viral
na
small
volum
kit
magna
pure
system
roch
diagnost
ul
type
sampl
ad
well
deep
well
plate
previous
fill
ul
extern
lysi
buffer
provid
kit
follow
incub
inactiv
viru
rna
extract
ul
eav
control
also
ad
well
rna
extract
perform
magna
pure
system
close
system
fulli
autom
ul
purifi
viru
rna
ad
preprepar
pcr
plate
well
contain
ul
pcr
reaction
buffer
biolog
safeti
cabinet
qpcr
reaction
perform
accord
instruct
reagent
prepar
sampl
purif
pcr
perform
separ
room
pass
window
avoid
cross
contamin
room
neg
pressur
buffer
room
chang
posit
control
standard
quantif
prepar
anoth
room
add
pcr
plate
sampl
extract
room
avoid
contamin
total
exclud
patient
die
within
hour
random
receiv
lopinavirritonavir
express
rate
differ
median
differ
hodgeslehmann
estim
confid
interv
hazard
ratio
estim
cox
proport
risk
model
clinic
deterior
rate
figur
proport
distribut
primari
endpoint
categori
intentiontotreat
popul
proport
sever
outcom
accord
ordin
scale
rang
discharg
normal
activ
death
hospit
unabl
resum
normal
activ
hospit
requir
supplement
oxygen
hospit
requir
supplement
oxygen
hospit
requir
highflow
nasal
oxygen
hfnc
andor
noninvas
mechan
ventil
imv
hospit
requir
ecmo
andor
imv
death
